Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Provid and Acesys Form US-China Medicinal Chemistry CRO Alliance

publication date: Sep 8, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Provid Pharmaceuticals of New Jersey and Acesys Pharmatech of China have formed a US-China CRO alliance. The new group puts together Provid’s US-based drug discovery expertise and project management capabilities with Acesys’s China-based medicinal chemistry resources and favorable cost structure. According to the announcement, the alliance will offer all aspects of medicinal chemistry for pharmaceutical and biotech clients. More details...

Stock Symbols: (HKEX: 2285) (NSDQ: CBTE) (NYSE: SGP) (NYSE: MRK)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...